Pharma companies want clarity on supplementary data in China Despite the Supreme Court’s proposal to lower the bar for post-filing patent data, innovators are sceptical that the provisions will have real impact By Karry Lai June 02 2020
Breeders split: EPO plant edict clarifies, stifles, misses mark Seed makers including Corteva are glad to have legal certainty after the Pepper ruling, but Bayer says it stems R&D and others have wider complaints By Patrick Wingrove June 01 2020
